Loading
Life sciences · Journal article
Scientific Reports · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Combined chemo-photothermal therapy as a synergistic approach has emerged to overcome the limitations of conventional chemotherapy. In this study, multifunctional polypyrrole-based nanoparticles were developed for targeted chemo-photothermal therapy of prostate cancer. In the first stage, the effect of polypyrrole backbone oxidative defects on the photothermal properties of nanoparticles was evaluated by changing the oxidant concentration during polymerization or chemical reduction of the structure post synthesis. The results showed an inverse relationship between the density of oxidative defects and the near-infrared (NIR) light absorption of the nanoparticles. To introduce active targeting capability to the system, hyaluronic acid (HA) was then conjugated onto the nanoparticle surface as a CD44-targeting ligand. Thereafter, the anticancer drug doxorubicin was loaded onto the nanoparticles, and drug release studies confirmed the photothermal responsiveness of the system. Cellular evaluations were performed on three common prostate cancer cell lines PC-3, DU145, and LNCaP, which exhibit different levels of CD44 expression. Chemotherapy alone demonstrated a significant size-dependent cytotoxic effect in CD44 positive cell lines, indicating the capability of the system for selective CD44 targeting. However, photothermal therapy induced cell death independent of CD44 expression levels. Finally, combined chemo-photothermal therapy induced a strong enhanced therapeutic effect, reducing cell viability to below 15% in all three cell lines, which represents a significant improvement compared to either treatment alone. The overall findings demonstrate the potential of the designed nanoparticles as a multifunctional platform for combined chemo-photothermal therapy of prostate cancer, particularly in the context of tumor heterogeneity and phenotypic differences among cancer cells.